Hennion & Walsh Asset Management’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
5,506
+480
| +10% | +$105K | 0.05% | 451 |
|
|
2025
Q1 | $1.13M | Buy |
5,026
+1,117
| +29% | +$250K | 0.05% | 448 |
|
|
2024
Q4 | $1.28M | Buy |
3,909
+580
| +17% | +$190K | 0.06% | 405 |
|
|
2024
Q3 | $999K | Buy |
3,329
+1,659
| +99% | +$498K | 0.05% | 452 |
|
|
2024
Q2 | $550K | Buy |
1,670
+664
| +66% | +$219K | 0.03% | 567 |
|
|
2024
Q1 | $398K | Buy |
+1,006
| New | +$398K | 0.02% | 625 |
|
|
2022
Q2 | – | Sell |
-730
| Closed | -$300K | – | 803 |
|
|
2022
Q1 | $300K | Sell |
730
-7
| -0.9% | -$2.88K | 0.02% | 656 |
|
|
2021
Q4 | $346K | Sell |
737
-13
| -2% | -$6.1K | 0.02% | 619 |
|
|
2021
Q3 | $318K | Sell |
750
-3
| -0.4% | -$1.27K | 0.02% | 623 |
|
|
2021
Q2 | $270K | Sell |
753
-15
| -2% | -$5.38K | 0.01% | 643 |
|
|
2021
Q1 | $216K | Buy |
+768
| New | +$216K | 0.01% | 658 |
|